Cancer Institute A national cancer institute
designated cancer center

Matthew Bogyo

Publication Details

  • Specificity of aza-peptide electrophile activity-based probes of caspases CELL DEATH AND DIFFERENTIATION Sexton, K. B., Kato, D., Berger, A. B., Fonovic, M., Verhelst, S. H., Bogyo, M. 2007; 14 (4): 727-732

    Abstract:

    Activity-Based Probes (ABPs) are small molecules that form stable covalent bonds with active enzymes thereby allowing detection and quantification of their activities in complex proteomes. A number of ABPs that target proteolytic enzymes have been designed based on well-characterized mechanism-based inhibitors. We describe here the evaluation of a novel series of ABPs based on the aza-aspartate inhibitory scaffold. Previous in vitro kinetic studies showed that this scaffold has a high degree of selectivity for the caspases, clan CD cysteine proteases activated during apoptotic cell death. Aza-aspartate ABPs containing either an epoxide or Michael acceptor reactive group were potent labels of executioner caspases in apoptotic cell extracts. However they were also effective labels of the clan CD protease legumain and showed unexpected crossreactivity with the clan CA protease cathepsin B. Interestingly, related aza peptides containing an acyloxymethyl ketone reactive group were relatively weak but highly selective labels of caspases. Thus azapeptide electrophiles are valuable new ABPs for both detection of a broad range of cysteine protease activities and for selective targeting of caspases. This study also highlights the importance of confirming the specificity of covalent protease inhibitors in crude proteomes using reagents such as the ABPs described here.

    View details for DOI 10.1038/sj.cdd.4402074

    View details for Web of Science ID 000245102900009

    View details for PubMedID 17170749

Stanford Medicine Resources:

Footer Links: